MedTrace Logo

Long-Term Follow-Up Study of Human Stem Cells Transplanted in Subjects With Connatal Pelizaeus-Merzbacher Disease (PMD)

NCT01391637 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2016-05-13

No results posted yet for this study

Summary

The purpose of this study is to determine the long term safety and preliminary effect of HuCNS-SC cells transplanted in subjects with Connatal Pelizaeus-Merzbacher Disease (PMD).

Conditions

  • Pelizaeus-Merzbacher Disease
  • PMD

Interventions

BIOLOGICAL

HuCNS-SC transplant in the lead-in phase

Long-term safety follow-up study

Sponsors & Collaborators

  • StemCells, Inc.

    lead INDUSTRY

Principal Investigators

  • Stephen Huhn, MD · StemCells, Inc.

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01391637 on ClinicalTrials.gov